Dr. Cora Sternber and the Uromigos discuss AMG 160, a half-life extended (HLE) bispecific T-cell engager (BITE®) antibody construct, and the future of immunotherapy in CRPC.
The Uromigos Episode 60: Cora Sternberg Discusses AMG 160, Bispecific Antibody in Prostate Cancer
By The Uromigos - Last Updated: September 21, 2020
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.